Laser Resurfacing Versus Dermabrasion for Scar Revision

Cicatrix Clinical Trial

Official title:

A Comparison Evaluation of Fractional Laser Therapy and Dermabrasion for Scar Revision

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01176448
• Other study ID #: 1001M75732-2
• Status: Completed
• Phase: N/A
• Start date: April 2010
• Est. completion date: September 2010

Study information

• Verified date: October 2019
• Source: University of Minnesota
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Dermabrasion has been the historical standard used for resurfacing scars on the skin. Recently, fractionated laser therapy has been FDA approved for scar resurfacing. This study intends to compare dermabrasion versus fractionated laser therapy for scar resurfacing.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 6
• Est. completion date: September 2010
• Est. primary completion date: August 2010
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Post-surgical or post traumatic scar on face or scalp.

• Age 18 or older

• Able to read and comprehend English

• Willing to follow treatment schedule and post treatment care requirements

• Signed the informed consent form

• Fitzpatrick skin type I-III

Exclusion Criteria:

• known photosensitivity

• Taken any medications known to induce photosensitivity in previous three months

• Taken Accutane within past 12 months

• Pregnant or nursing

• Currently on topical or oral antibiotics

• Immunocompromised status

• Skin type IV or greater

Related Conditions & MeSH terms

• Cicatrix
• Coagulation, Laser
• Dermabrasion

Intervention

Device:
• Fractionated laser
Fractionated laser in the form of the Re:Pair CO2 laser manufactured by Solta Medical.
• Dermabrasion
Diamond Fraise Dermabrasion will be performed in standard fashion down to papillary dermis.

Locations

Country	Name	City	State
United States	Zel Skin and Laser	Edina	Minnesota

Sponsors (1)

Lead Sponsor	Collaborator
University of Minnesota

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Safey Data Score Based on Ordinal Ratings of Erythema, Edema, Bleeding, Eschar After Resurfacing	Erythema, edema, bleeding, and eschar after resurfacing were used as indicators of safety. Each was judged based on a 4 point ordinal scale 0=absent, 1=mild, 2=moderate, 3=severe.	Day 0, Week1, Month 1
Secondary	Visual Analog Scale for Assessing Scar Improvement.	Visual Analog Scale for assessing scar improvement. 0 : Worsening or no improvement; : 1-25% improvement; : 26-50% improvement; : 51-75% improvement; : 76-100% improvement	3 months